Mohammed Munavvar

Mr Munavvar Job title: Consultant Chest Physician and Director of R&D

Department: Chest Medicine

Telephone number: 01772 522416 / 8268 / 2412

Primary medical qualification: MBBS (1987)

Other qualifications: MD DNB FRCP FRCP Edin

Year of registration: 1993

GMC number: 4324056

Career history: Consultant Chest Physician, Royal Preston Hospital since 1999. Dr Munavvar has been in post as the Secretary for the European Association for Bronchology and Interventional Pulmonology (EABIP) since 2014, and we are delighted to announce that as of 2017, he has been named President-Elect of the association; a role that he will fill for two years before taking on the honour of President.

Specialist areas: Interventional Bronchoscopy, Thoracoscopy, TB, Lung Cancer, Sarcoidosis, Mesothelioma and other respiratory diseases

Specialist interests: As above

Research interests: Innovative techniques in bronchoscopy, thoracoscopy, pleural diseases

Clinics: General Respiratory, Lung Cancer, TB and Pleural diseases

Languages spoken: English, Urdu, Hindi, Tamil

News

Back to the list

New equipment to detect lung cancer earlier than ever before

EBUS

We are the first hospital outside London, to install new cutting-edge technology used to detect early signs of lung cancer.

The new ultrasound technology, which has been installed at our Rosemere Cancer centre at Royal Preston Hospital, enables us to assess patients suspected of lung cancer at a much earlier stage and gives better images than ever before, in a much safer and less invasive way.

The Endobronchial Ultrasound (known as EBUS) allows our Consultants to obtain tissue or fluid samples from the lungs and surrounding area without the patient having to undergo surgery. It also means we can reach and analyse hard to reach areas much more easily.

Lung cancer is the Country’s biggest cancer killer. It claims the lives of over 35,000 people every year.

EBUS large Dr Mohammed Munavvar, Consultant in Respiratory Medicine at Lancashire Teaching Hospitals NHS Foundation Trust, said: “I had the privilege of being invited to Japan to evaluate this innovative equipment and we are delighted to have it here at Royal Preston hospital. Currently just nine percent of lung cancer patients survive for five years or more, but we are confident that this new technology will help us to save more lives and the procedure is far more comfortable and less invasive for the patient.”

Karen Partington, Chief Executive at Lancashire Teaching Hospitals NHS Foundation Trust, said: “We are delighted to be leading the way in lung cancer treatment and we are confident that this new cutting-edge equipment will make a real difference to the lives of our patients.”

The equipment is currently at Royal Preston hospital on loan as it costs £100,000 to keep it here permanently. Rosemere Cancer Foundation are fundraising to try and get the money needed, if you want to get involved in fundraising please visit the Rosemere website http://www.rosemere.org.uk/ or call 01772 522913

The equipment has been secured on loan to Royal Preston Hospital thanks to a generous donation of £27,444 from the Furness Building Society and the Rosemere Cancer Foundation has launched a fundraising campaign to raise the £100,000 needed to keep it in Preston for the long term.  To get involved or make a donation, please email info@rosemere.org.uk or call 01772 522913.

We are delighted to be leading the way in lung cancer treatment and we are confident that this new cutting-edge equipment will make a real difference to the lives of our patients